<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Biotechnology Company</title>
	<atom:link href="http://www.straightstocks.com/tag/biotechnology-company/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Wed, 25 Nov 2009 04:39:17 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>OmniComm Systems, Inc. (OMCM.OB) Has Another Record Breaking Quarter</title>
		<link>http://www.straightstocks.com/current-market-news/omnicomm-systems-inc-omcmob-has-another-record-breaking-quarter/</link>
		<comments>http://www.straightstocks.com/current-market-news/omnicomm-systems-inc-omcmob-has-another-record-breaking-quarter/#comments</comments>
		<pubDate>Mon, 07 Jul 2008 20:33:40 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Biotechnology Research]]></category>
		<category><![CDATA[Clinical Trial Research]]></category>
		<category><![CDATA[Clinical Trials]]></category>
		<category><![CDATA[Coo]]></category>
		<category><![CDATA[Customer Base]]></category>
		<category><![CDATA[Data Capture Solutions]]></category>
		<category><![CDATA[Electronic Data]]></category>
		<category><![CDATA[Loyal Customers]]></category>
		<category><![CDATA[Medical Device]]></category>
		<category><![CDATA[New Business]]></category>
		<category><![CDATA[New Partners]]></category>
		<category><![CDATA[Omnicomm Systems Inc]]></category>
		<category><![CDATA[Partnership Programs]]></category>
		<category><![CDATA[Personal Attention]]></category>
		<category><![CDATA[Pharmaceutical Biotechnology]]></category>
		<category><![CDATA[Preferred Partnership]]></category>
		<category><![CDATA[Recipe For Success]]></category>
		<category><![CDATA[Second Quarter]]></category>
		<category><![CDATA[Straight Quarter]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10970</guid>
		<description><![CDATA[For the third straight quarter in a row, OmniComm Systems, a leader in integrated electronic data capture solutions for clinical trials, is reporting another landmark quarter for new business. The company has surpassed its previous best quarter and signed contracts through the first two quarters of 2008 totaling almost $12 million, which surpass all of [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/omnicomm-systems-inc-omcmob-has-another-record-breaking-quarter/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TapImmune, Inc. (TPIM.OB) Lead Product Receives Medical Attention</title>
		<link>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/</link>
		<comments>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/#comments</comments>
		<pubDate>Tue, 03 Jun 2008 21:20:16 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Antigen Processing]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Cancer Cells]]></category>
		<category><![CDATA[Cancer Markers]]></category>
		<category><![CDATA[Cancer Therapy]]></category>
		<category><![CDATA[Cancerous Cells]]></category>
		<category><![CDATA[Clinical Evaluation]]></category>
		<category><![CDATA[Immunotherapeutics]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Initial Description]]></category>
		<category><![CDATA[Journal Of Investigative Dermatology]]></category>
		<category><![CDATA[Malignant Melanoma]]></category>
		<category><![CDATA[Medical Attention]]></category>
		<category><![CDATA[Otcbb]]></category>
		<category><![CDATA[Research Article]]></category>
		<category><![CDATA[Rogue Cells]]></category>
		<category><![CDATA[S Trading]]></category>
		<category><![CDATA[Treatment Of Cancer]]></category>
		<category><![CDATA[Tumor Recognition]]></category>
		<category><![CDATA[Viral Antigens]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10447</guid>
		<description><![CDATA[TapImmune, Inc. (OTCBB: TPIM) announced that their TAP incorporated vaccine for the treatment of cancer was recently reviewed by a third party research article in the Journal of Investigative Dermatology, which confirmed that the company&#8217;s vaccine should be considered as a therapy for cancer.  
The article, entitled, &#8220;Restoration of the Expression of Transporters Associate [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/tapimmune-inc-tpimob-lead-product-receives-medical-attention/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dutton Associates Featured Company: Viral Genetics Inc. (VRAL.PK)</title>
		<link>http://www.straightstocks.com/current-market-news/dutton-associates-featured-company-viral-genetics-inc-vralpk/</link>
		<comments>http://www.straightstocks.com/current-market-news/dutton-associates-featured-company-viral-genetics-inc-vralpk/#comments</comments>
		<pubDate>Tue, 03 Jun 2008 19:53:19 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adjuvant]]></category>
		<category><![CDATA[Autoimmune Conditions]]></category>
		<category><![CDATA[Autoimmune Deficiency]]></category>
		<category><![CDATA[Azusa California]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Desperate Need]]></category>
		<category><![CDATA[Diagnostic Products]]></category>
		<category><![CDATA[Dutton Associates]]></category>
		<category><![CDATA[Hiv Aids]]></category>
		<category><![CDATA[Hiv Infection And Aids]]></category>
		<category><![CDATA[Hiv Viral Load]]></category>
		<category><![CDATA[Novel Mechanism]]></category>
		<category><![CDATA[Nuclear Protein]]></category>
		<category><![CDATA[Stage Development]]></category>
		<category><![CDATA[Stage Of Development]]></category>
		<category><![CDATA[Thymus]]></category>
		<category><![CDATA[Thymus Tissue]]></category>
		<category><![CDATA[Treatment Of Hiv]]></category>
		<category><![CDATA[Viral Genetics Inc]]></category>
		<category><![CDATA[World Health Organization]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10442</guid>
		<description><![CDATA[Viral Genetics Inc. is a biotechnology company with a focus on protein-based therapeutic and diagnostic products with applications in infectious disease, autoimmune conditions, and immunological deficiency. The company and its management team are key players in the fight against HIV/AIDS, infectious disease, and autoimmune deficiency. Viral Genetics has been working since 1995 to find a [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/dutton-associates-featured-company-viral-genetics-inc-vralpk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Shares of Kosan Biosciences, Inc. (KOSN) Surge on Agreement to be Acquired by Bristol-Myers for $5.50 per Share</title>
		<link>http://www.straightstocks.com/current-market-news/shares-of-kosan-biosciences-inc-kosn-surge-on-agreement-to-be-acquired-by-bristol-myers-for-550-per-share/</link>
		<comments>http://www.straightstocks.com/current-market-news/shares-of-kosan-biosciences-inc-kosn-surge-on-agreement-to-be-acquired-by-bristol-myers-for-550-per-share/#comments</comments>
		<pubDate>Fri, 30 May 2008 02:11:14 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Current Market News]]></category>
		<category><![CDATA[OTCBB Markets]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Anticancer Drugs]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[Biotechnology Company]]></category>
		<category><![CDATA[Boards Of Directors]]></category>
		<category><![CDATA[Bristol Myers]]></category>
		<category><![CDATA[Bristol Myers Squibb]]></category>
		<category><![CDATA[Definitive Merger Agreement]]></category>
		<category><![CDATA[Drug Developer]]></category>
		<category><![CDATA[Genetic Manipulation]]></category>
		<category><![CDATA[Initial Payment]]></category>
		<category><![CDATA[Kosan Biosciences Inc]]></category>
		<category><![CDATA[Kosn]]></category>
		<category><![CDATA[Milestone Payments]]></category>
		<category><![CDATA[Outstanding Shares]]></category>
		<category><![CDATA[Polyketides]]></category>
		<category><![CDATA[Product Candidates]]></category>
		<category><![CDATA[Purchase Agreement]]></category>
		<category><![CDATA[Royalty Payments]]></category>
		<category><![CDATA[Share Shares]]></category>
		<category><![CDATA[Technology Assets]]></category>
		<category><![CDATA[Worldwide License]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=10380</guid>
		<description><![CDATA[Shares of Kosan Biosciences Inc. (NASDAQ: KOSN), a biotechnology company and drug developer that focuses on the genetic manipulation of polyketides, which are used in antibiotics and anticancer drugs, more than tripled recently on the announcement of the signing of a definitive merger agreement with Bristol-Myers Squibb. Under the terms of the agreement, Bristol-Myers Squibb [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/current-market-news/shares-of-kosan-biosciences-inc-kosn-surge-on-agreement-to-be-acquired-by-bristol-myers-for-550-per-share/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
